Indication

Haemophilus parainfluenzae bronchitis

*Haemophilus parainfluenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucosa caused by *Haemophilus parainfluenzae*, a Gram-negative opportunistic coccobacillus. Read more about Haemophilus parainfluenzae bronchitis

97 drugs 57 manufacturers

Advertisement

Drugs that treat it

Common Haemophilus parainfluenzae bronchitis therapies.

Showing 10–18 of 97 drugs

CEFDINIR

PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+15
SANDOZ
Filter & compare in the drug finder →Opens the drug finder with Haemophilus parainfluenzae bronchitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Haemophilus parainfluenzae bronchitis.

*Haemophilus parainfluenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucosa caused by *Haemophilus parainfluenzae*, a Gram-negative opportunistic coccobacillus.

It most commonly manifests as an acute bronchitis or an acute bacterial exacerbation of chronic bronchitis in adults, particularly individuals with underlying chronic obstructive pulmonary disease, impaired mucociliary clearance, or compromised immune defenses.

Pathophysiologically, the organism colonizes the tracheobronchial epithelium, triggering neutrophil infiltration, mucosal edema, and hypersecretion of mucus.

Clinically, affected patients present with a persistent cough, increased volume or purulence of sputum, chest congestion, wheezing, and varying degrees of dyspnea.

Personalize your experience

Follow Haemophilus parainfluenzae bronchitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it